Oruka Therapeutics is developing novel biologics designed to set a new standard for the treatment of chronic skin diseases. Oruka's mission is to offer patients suffering from chronic skin diseases like plaque psoriasis the greatest possible freedom from their condition by achieving high rates of complete disease clearance with dosing as infrequently as one or twice a year. Oruka is advancing a proprietary portfolio of potentially best-in-class antibodies that were engineered by Paragon Therapeutics and target the core mechanisms underlying plaque psoriasis and other dermatologic and inflammatory diseases.

https://www.orukatx.com/

Oruka Therapeutics

https://arcabio.com/

Berat

ARCA biopharma

ARCA biopharma, Inc., a precision medicine-focused biopharmaceutical company, has announced a merger agreement with Oruka Therapeutics, Inc. The merger is intended to qualify for federal income tax purposes as a tax-free reorganization and is highly dependent on the success of the companies' future operations.

ARCA biopharma merges with Oruka Therapeutics to strengthen precision medicine approach

ARCA biopharma merges with Oruka Therapeutics to strengthen precision medicine approach

Company Info

Unlock Strategic Intelligence with Fundz